National Vision Holdings, Inc.: management transactions · United States · SEC (Form 4)

About National Vision Holdings, Inc.

National Vision Holdings, Inc. (ticker: EYE) is a U.S.-based specialty retailer in vision care, listed on the NASDAQ in the United States. The company operates a value-oriented model focused on making eye exams, eyeglasses, contact lenses, and related services more affordable and accessible. Its business sits at the intersection of healthcare and retail, combining in-store optical services with an omnichannel consumer platform. National Vision’s roots trace back to National Vision, Inc., whose growth was built through acquisitions and network expansion. National Vision Holdings was incorporated in 2014, and the company completed its IPO in 2017. Headquartered in Duluth, Georgia, the group has developed around a relatively disciplined low-cost operating platform and a value proposition aimed at price-sensitive consumers. That positioning matters in the highly fragmented U.S. optical retail market, where competition comes from national chains, independent opticians, mass merchants, and online players. The company’s operating model is built around four brands and channels: America’s Best, Eyeglass World, Vista Opticals located inside select Fred Meyer stores and on select military bases, and the e-commerce site DiscountContacts.com. Across these banners, National Vision sells prescription eyeglasses, contact lenses, eye exams, and various vision-care services. The mix of physical retail, professional eye-care services, and online replenishment gives the company multiple customer touchpoints and some recurring revenue characteristics, especially in contact lenses and lens-related products. From a competitive standpoint, National Vision is positioned as a significant value player in the U.S. optical retail landscape, with a strategy that emphasizes store openings, traffic growth, and operational execution. Recent corporate messaging has highlighted a broader transformation plan designed to improve profitability, strengthen the company’s footprint in the estimated $70 billion U.S. optical retail market, and support more sustainable long-term growth. Recent earnings updates have pointed to improving comparable-store sales and margin trends, while management has also raised parts of its fiscal 2025 outlook and outlined longer-term financial objectives. For French-speaking investors, EYE is best viewed as a U.S. consumer-health and specialty retail name rather than a pure healthcare provider. Its investment case is driven by execution on store productivity, pricing discipline, and the success of its multi-year transformation, all within the context of the NASDAQ-listed equity market in the United States.